Belite Bio Inc.
- Address
- Ugland House, P. O. Box 309
Sponsor Overview
Specializations
Inherited Retinal Disease
Belite Bio Inc. focuses on clinical research in Stargardt disease, with attention to adolescent populations affected by progressive retinal degeneration and atrophic lesion growth.
- Stargardt disease
- Adolescent retinal degeneration
- Atrophic lesion progression
The sponsor’s work in this area centers on preserving visual function and addressing the course of inherited macular disease.
Geographic Atrophy
The clinical portfolio includes studies in geographic atrophy, a late-stage form of age-related macular degeneration characterized by progressive loss of retinal tissue and enlargement of GA lesions.
- Geographic atrophy
- Age-related macular degeneration
- Retinal lesion enlargement
Research activity in this domain reflects interest in slowing structural retinal damage and monitoring disease progression in the macula.
Ophthalmic Safety and Tolerability
Belite Bio Inc. also studies the systemic and ocular safety profile of therapies used in retinal disease, with emphasis on long-term tolerability in patients with chronic eye conditions.
- Systemic safety
- Ocular tolerability
- Long-term treatment monitoring
This area supports continued evaluation of treatment suitability for extended use in inherited and degenerative retinal disorders.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Tinlarebant Efficacy and Safety in Adolescents with Stargardt Disease: A Phase 3 Randomized, Double-Masked, Placebo-Controlled Trial |  Belgium France Germany The Netherlands | Not Recruiting |
| Phase 3 Multicenter Randomized Double-Masked Placebo-Controlled Trial of Tinlarebant in Geographic Atrophy Treatment |  Czechia France | Recruiting |
| Safety and Tolerability of Tinlarebant in Subjects with Stargardt Disease: An Open-Label, Single-Arm, 3-Year Extension Study | Belgium France The Netherlands | Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 12 sites across their trial portfolio.
Therapeutic Focus
- 1.Eye Diseases3 trials138 other sponsors
Partnered Research Centres
12 centres- Address
- Ostrovskeho 253/3, Smichov, 150 00 Prague
- Address
- 14 Rue Paul Gaffarel, 21000 Dijon
- Address
- 433 Rue Paradis, 13008 Marseille
- Address
- 103 Grande Rue De La Croix Rousse, 69317 Lyon
- Address
- Videnska 800, Krc, 140 00 Prague
- Address
- 39 Chemin De La Vernique, 69130 Ecully
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Belite Bio Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.